1. Home
  2. AKYA vs ELA Comparison

AKYA vs ELA Comparison

Compare AKYA & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKYA
  • ELA
  • Stock Information
  • Founded
  • AKYA 2015
  • ELA 1965
  • Country
  • AKYA United States
  • ELA United States
  • Employees
  • AKYA N/A
  • ELA N/A
  • Industry
  • AKYA Medical Specialities
  • ELA Consumer Specialties
  • Sector
  • AKYA Industrials
  • ELA Consumer Discretionary
  • Exchange
  • AKYA Nasdaq
  • ELA Nasdaq
  • Market Cap
  • AKYA 145.5M
  • ELA 138.2M
  • IPO Year
  • AKYA 2021
  • ELA N/A
  • Fundamental
  • Price
  • AKYA $3.06
  • ELA $5.34
  • Analyst Decision
  • AKYA Buy
  • ELA
  • Analyst Count
  • AKYA 9
  • ELA 0
  • Target Price
  • AKYA $6.08
  • ELA N/A
  • AVG Volume (30 Days)
  • AKYA 151.1K
  • ELA 10.7K
  • Earning Date
  • AKYA 11-06-2024
  • ELA 11-06-2024
  • Dividend Yield
  • AKYA N/A
  • ELA N/A
  • EPS Growth
  • AKYA N/A
  • ELA N/A
  • EPS
  • AKYA N/A
  • ELA 0.24
  • Revenue
  • AKYA $93,216,000.00
  • ELA $155,923,461.00
  • Revenue This Year
  • AKYA $3.46
  • ELA N/A
  • Revenue Next Year
  • AKYA $20.67
  • ELA $10.07
  • P/E Ratio
  • AKYA N/A
  • ELA $21.83
  • Revenue Growth
  • AKYA 9.66
  • ELA N/A
  • 52 Week Low
  • AKYA $1.88
  • ELA $3.02
  • 52 Week High
  • AKYA $6.31
  • ELA $5.80
  • Technical
  • Relative Strength Index (RSI)
  • AKYA 55.81
  • ELA 50.53
  • Support Level
  • AKYA $2.86
  • ELA $5.23
  • Resistance Level
  • AKYA $3.26
  • ELA $5.40
  • Average True Range (ATR)
  • AKYA 0.22
  • ELA 0.15
  • MACD
  • AKYA 0.01
  • ELA -0.02
  • Stochastic Oscillator
  • AKYA 73.20
  • ELA 54.55

About AKYA Akoya BioSciences Inc.

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

About ELA Envela Corporation

Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

Share on Social Networks: